March 18, 2019
At the American College of Cardiology this past weekend, chronic disease management platform Livongo reported on six-month results from its first major study of its hypertension management platform, which is already in use with many of its customers.
The study looked at 708 individuals with both diabetes and hypertension. Patients whose blood pressure was higher than 130/80 mm Hg saw their...
March 7, 2019
It's been a while since the digital health space has seen an IPO. But that's about to change, according to The Wall Street Journal, which reports that chronic disease management startup Livongo Health is planning to go public this year.
According to the Journal, the company has hired Morgan Stanley, Goldman Sachs and JPMorgan Chase as underwriters, and is looking towards a valuation over $1...
February 28, 2019
Livongo previews hypertension chatbot. Chronic condition management company Livongo unveiled a new feature it plans to add to its hypertension offering: a voice-enabled chatbot, powered by Amazon Lex. Livongo announced new feature at the company’s SIGNUM conference for clients and members, which begins today.
With the new system, the voice assistant will deliver “Health Nudges”— such as nutrition...
February 4, 2019
Dr. Karen DeSalvo, formerly an acting assistant secretary for health at the Department of Health and Human Services and the chief of the Office of the National Coordinator for Health Information Technology, has joined digital venture platform LRVHealth as an executive advisor.
“My entire career has been focused on improving the health of people and communities by catalyzing solutions to address...
January 30, 2019
Chronic condition management startup Livongo has acquired MyStrength, a Denver-based digital behavioral health company. The company did not disclose the acquisition price, but Livongo CEO Glen Tullman told Babyforyou.net.ua the figure is in the tens of millions.
“This entry into behavioral was to complete what we call the whole person platform, and to be able to go to someone and say ‘Whatever...
November 21, 2018
Livongo’s DPP recogized by the CDC. Digital chronic care company Livongo Health’s Diabetes Prevention Program has received full recognition from the CDC, according to a release from the company. The designation implies that the digital offering meets the agency’s standards as a Type 2 diabetes prevention and lifestyle change intervention, and is listed within the CDC’s online referral tool.
November 1, 2018
Chronic disease management startup Livongo announced a handful of new offerings and partnerships this week, all organized around the theme of “Applied Health Signals,” a framework for thinking about the technologies and capabilities Livongo offers.
“Health Signals is really an enabling technology,” Amar Kendale, Livongo’s chief product officer, told Babyforyou.net.ua. “Something that is part of all...
September 19, 2018
Focus on Innovation
In September, we take a deep dive into the cutting-edge development and disruption of healthcare innovation.
September 17, 2018
Today at Health 2.0 in Santa Clara, California, chronic disease management platform Livongo announced the launch of what it says is the US’s first cellular-enabled blood pressure monitoring system.
The company said during a presentation that the system will allow users to take and report their blood pressure at home, which may offer more accurate readings for those who experience anxiety in a...
September 5, 2018
Correction: A previous version of this article failed to specify that the deal concerns Freestyle Libre Pro, rather than the consumer version, Freestyle Libre.
Livongo Health, the digital chronic disease management company founded by former Allscripts CEO Glen Tullman, announced today that it will be the first United States enterprise diabetes management company to bring Abbott’s Freestyle Libre...